Lithium stocks have received a lot of attention lately, thanks largely to Tesla Motors' giant lithium-ion battery factory. Here are the ones investors should focus on.
Before Dow and DuPont merge to create DowDuPont, is the stock already a buy?
Knowing how Dow Chemical recovered from big losses could shed light on potential future successes.
Recent moves by DuPont suggest the company is already treating its merger and split with Dow Chemical as a foregone conclusion. Should it be so confident?
Investors looking for income and value should take a closer look at these cheap stocks.
Licensing a next-generation gene editing tool called CRISPR could greatly reduce time to market for future agricultural products and save the company hundreds of millions of dollars in expenses.
Share movements -- or a lack thereof -- show investors aren't sure the takeover will go through as planned.
The chemical giant is throwing resources at its agriculture business at the expense of its other units -- which might be a boon for rival 3M.
JPMorgan thinks Monsanto is a good buy today. This Fool begs to differ.
Just when the Dow-DuPont merger was looking like a done deal, the U.S. Senate decided to get involved. Is this cause for alarm?